首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING TILIANIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PARKINSON'S DISEASE

PHARMACEUTICAL COMPOSITION CONTAINING TILIANIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PARKINSON'S DISEASE

机译：包含蒂利亚宁作为预防或治疗帕金森氏病的有效成分的药物组合物

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a pharmaceutical composition and health functional food for prevention or treatment of Parkinson's disease, each containing a composite extract composed of Agastachis Herba containing tilianin, Paeonia lactiflora, Ligusticum chuanxiong, Angelica gigas, Bupleurum falcatum, Gardenia jasminoides, Paeonia suffruticosa, and Eugenia caryophyllata. The composition of the present invention improves behavioral disorders induced by MPTP and restores the loss of dopaminergic neurons, and thus has excellent effects in the prevention, alleviation, and treatment of Parkinson's disease.

机译：本发明涉及一种用于预防或治疗帕金森氏病的药物组合物和保健功能食品，每种药物均包含由含有天麻素的，草、,药，Pa药，川gust的组合提取物。 >，， Bupleurum falcatum ， Jardenia jasminoides ， Paeonia suffruticosa 和 Eugenia caryophyllata 。本发明的组合物改善了由MPTP引起的行为障碍并恢复了多巴胺能神经元的损失，因此在预防，减轻和治疗帕金森氏病方面具有优异的效果。 展开▼

著录项

公开/公告号WO2018208128A1

专利类型

公开/公告日2018-11-15

原文格式PDF

申请/专利权人 UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY;INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY;DONGKWANG PHARMACEUTICAL CO. LTD.;
展开▼

申请/专利号WO2018KR05458

发明设计人 PARK SEONG UK;PARK HI-JOON;JEON SONG HEE;KIM YOUNG MAN;CHO SEUNG YEON;AHN SORA;KIM DONG HEE;JEONG GUWON;OH SEUNG TACK;
展开▼

申请日2018-05-11

分类号A61K36/65;A61K36/234;A61K36/232;A61K36/233;A61K36/744;A61K36/53;A61K36/61;A23L33/105;

国家 WO

入库时间 2022-08-21 11:58:07

相似文献

专利

外文文献

中文文献

1. 包含O-环植物鞘氨醇-1-磷酸酯的用于预防或治疗帕金森氏病的组合物 [P] . 中国专利： CN114080227A . 2022-02-22

2. 包含阿莫地喹及抗糖尿病药物作为有效成分的用于预防或治疗糖尿病的药学组合物 [P] . 中国专利： CN109640993B . 2021.07.09

3. Pharmaceutical composition for prevention or treatment of Parkinson's disease comprising tilianin [P] . 韩国专利： KR101805801B1 . 2017-12-13

机译：用于预防或治疗帕金森氏病的药物组合物，其包含tilianin

4. A pharmaceutical composition containing N-terminal Truncated Ubiquitin C-terminal hydrolase-L1 as a active ingredient for the prevention and treatment of parkinson's disease [P] . 韩国专利： KR101384642B1 . 2014-04-22

机译：包含N末端截短的泛素C末端水解酶-L1作为预防和治疗帕金森氏病的有效成分的药物组合物

5. A PHARMACEUTICAL COMPOSITION CONTAINING N-TERMINAL TRUNCATED UBIQUITIN C-TERMINAL HYDROLASE-L1 AS A ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE [P] . 韩国专利： KR20140000733A . 2014-01-06

机译：包含N末端截短泛肽C末端水解酶L1的药物组合物，是预防和治疗帕金森氏病的有效成分

1. Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis [J] . Yuki Maeda, Keiichi Motoyama, Taishi Higashi, 亚洲药物制剂科学(英文) . 2016,第001期

2. Function and mechanism of traditional Chinese medicine in the prevention and treatment of Parkinson＇s disease [J] . Ting Zhang, Ke Wang, Limin Liu, 转化神经科学电子杂志（英文） . 2017,第004期

3. Function and mechanism of traditional Chinese medicine in the prevention and treatment of Parkinson's disease [J] . Ting Zhang, Ke Wang, Limin Liu, 转化神经科学电子杂志（英文） . 2017,第004期

4. TREATMENT OF SKIN CHRONIC WOUNDS IN ELDERLY PATIENTS WITH TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT A MIXTURE OF POLLEN EXTRACT AND VEGETABLE OIL UNSAPONIFIABLES: PRELIMINARY DATA ON A PERSONAL SERIES [J] . Ragno A., Marsili D., Martin L. S. M., Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society . 2015,第4期

5. FOAMABLE COMPOSITION ESSENTIALLY FREE OF PHARMACEUTICALLY ACTIVE INGREDIENTS FOR THE TREATMENT OF HUMAN SKIN [J] . Soap Perfumery and Cosmetics group Soap, Perfumery and Cosmetics . 2015,第8期

6. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities [J] . Arshad H Rahmani, Fahad M Al shabrmi, Salah M Aly International Journal of Physiology, Pathophysiology and Pharmacology . 2014,第2期

7. Start-up of a High Purity Oxygen Sequencing Batch Reactor System for Treatment of an Active Pharmaceutical Ingredient (API) Wastewater [C] . Erika Lubkowitz-Bailey, Christine Ryan, Charles Reith Jr., Water Environment Federation 75th annual technical exhibition amp; conference (WEFTEC 2002) . 2002

8. Improved Characterization of Pure and Formulated Active Pharmaceutical Ingredients by Fast Magic Angle Spinning Solid-State NMR Spectroscopy [D] . Wijesekara, Anuradha V. 2020

9. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities [O] . Arshad H Rahmani, Fahad M Al shabrmi, Salah M Aly 2014

10. CHALLENGES AND PROSPECTS OF ALGAL BIOTECHNOLOGY FOR THE ISOLATION AND CHARACTERIZATION OF ACTIVE PHARMACEUTICAL INGREDIENT (API) ON THE EXAMPLE OF NEW GLUTAMINYL CYCLASE (QC) INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE [O] . Krause–Hielscher S., Griehl C. 2014

1. Network pharmacology-based virtual screening of active alkaloid ingredients from Piper nigrum L.and the potential targets against Parkinson’s disease [J] . Ye Chang ,Yuxi Wang ,Xiaoxiao Huang . 亚洲传统医药 . 2021,第004期

2. Highly Active Antiretroviral Treatment (HAART) for the Prevention of HIV Mother to Child Transmission (PMTCT) at Roosevelt Hospital's Infectious Diseases Clinic in Guatemala: The Role of (LPV/r) Standard Dose [J] . Carlos Mejia Villatoro ,Maria Eugenia Luarte ,Guillermo Villatoro Natareno . 艾滋病（英文） . 2012,第3期

3. 北京地区帕金森病药物治疗状况的调查及我国帕金森病治疗指南对药物治疗影响的研究 [C] . 南海天 ,陈海波 . 第一届华北地区神经病学学术会议暨2013年北京地区神经病学学术年会 . 2013

4. 长苞凹舌兰有效成分Dactylorhin B和合成的新型化合物FLZ抗神经退行性病变（阿尔茨海默氏病，帕金森氏病）的作用及作用机制研究 [A] . 张丹 . 2006